• Thomas Wang, M.D., Ph.D., joined the UAB Department of Surgery Division of Surgical Oncology in 2007. Dr. Wang is a prolific author and researcher with over six book chapters and numerous publications. He presents his clinical and research findings on a national level. He is a committed medical educator serving as the Co-Director of the Surgical Oncology Conference—training both residents and medical students. In 2014, he received the Argus Award which recognized his excellence in post-doctoral teaching for hematology-oncology.

    Dr. Wang’s clinical interests include thyroid and parathyroid diseases, adrenal neoplasms, pancreatic and hepatobiliary tumors, gastrointestinal malignancies, melanoma and soft tissue sarcomas.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2018 How academically productive are endocrine surgeons in the United States? 2018
    2018 Reducing cost and improving operating room efficiency: examination of surgical instrument processing 2018
    2016 Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma. 2016
    2016 Improved postoperative survival for intraductal- growth subtype of intrahepatic cholangiocarcinoma 2016
    2016 Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma 2016
    2016 Timed Stair Climbing is the Single Strongest Predictor of Perioperative Complications in Patients Undergoing Abdominal Surgery 2016
    2016 Compromised Outcome of Papillary Thyroid Cancer at Low-Volume Treatment Centers: Practice Makes Perfect? 2016
    2015 Anaplastic thyroid carcinoma, version 2.2015 2015
    2014 Thyroid carcinoma, version 2.2014. 2014
    2014 Thyroid carcinoma, version 2.2014: Featured updates to the NCCN guidelines 2014
    2010 Thyroid carcinoma 2010
    2010 Medullary carcinoma. 2010
    2010 Medullary carcinoma: Clinical practice guidelines in oncology™ 2010
    2009 The role of angiocidin in sarcomas 2009
    2009 Fibroblast-conditioned media promote human sarcoma cell invasion 2009
    2005 Macrophage inflammatory protein-3α promotes pancreatic cancer cell invasion 2005
    2004 Co-localization of macrophage inflammatory protein-3α (Mip-3α) and its receptor, CCR6, promotes pancreatic cancer cell invasion 2004
    2004 Antiangiogenic therapy 2004
    2002 Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production 2002
    2001 Neoadjuvant therapy for gastric cancer 2001
    1997 Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells 1997
    1997 Adhesive proteins and the hematogenous spread of cancer 1997
    1997 Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system 1997
    1996 Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor 1996
    1996 Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer 1996
    1995 The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen 1995

    Research Overview

  • pancreatic, hepatobiliary and gastrointestinal malignancies, surgical endocrine diseases, optimization of surgical resident curriculum to focus on the conceptual understanding of disease processes and patient management
  • Education And Training

  • Hahnemann University Hospital, Internship 1992
  • Hahnemann University Hospital, Residency 1999
  • MD Anderson Cancer Center, Postdoctoral Fellowship 2001
  • Full Name

  • Thomas Wang